AHA-BUCH

Patent Law & Its Application to the Pharmaceutical Industry

 Paperback
Print on Demand | Lieferzeit:3-5 Tage I

39,90 €*

Alle Preise inkl. MwSt. | zzgl. Versand
ISBN-13:
9783659428463
Einband:
Paperback
Erscheinungsdatum:
24.05.2018
Seiten:
60
Autor:
Swapnil Khadke
Gewicht:
105 g
Format:
220x150x4 mm
Sprache:
Englisch
Beschreibung:

99
The development of drugs is costly for pharmaceutical companies, and without intellectual property law protection, the formula for the drugs can be easily duplicated and the drugs can be synthesized at a cheaper cost. Thus, intellectual properties laws often allow companies to monopolize the synthesis and sales of drugs. Unfortunately, this exclusive right to manufacture and sell drugs provides the necessary monetary incentive for drug discovery. The patent law is based upon the Patent Act of 1952, codified in Title 35 of the United States Code. This statute allows inventors to obtain patents on processes, machines, manufactures, and compositions of matter that are useful, new, and nonobvious. Granted patents confer the right to exclude others from making, using, selling, offering to sell, or importing into the United States the patented invention. This book covers issues through the year 2002, Modifications of the Hatch-Waxman Act were implemented in P.L. 108-173, the Medicare Prescription Drug and Modernization Act of 2003.